InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: Alexxdj1 post# 697

Tuesday, 01/07/2020 9:13:06 AM

Tuesday, January 07, 2020 9:13:06 AM

Post# of 977
Trillium is one of the best long-term holds. It just released data today and is the only anti-CD47 biotech to achieve complete response rates in blood cancers. Albeit at low doses. This is a buyout candidate easily or a a partnership to come.

https://finance.yahoo.com/news/trillium-therapeutics-provides-tti-621-133010015.html